ArtinVet, Advanced Regenerative Therapies in Veterinary, comes from the union of Histocell, a leading company in regenerative medicine and Univet, a company specialized in dermatology veterinary, with Spherium Biomed's innovative support.
Histocell is a Noray Biosciences Group biopharmaceutical company specialized in Tissue Engineering and Cell Therapy products for Regenerative Medicine. Currently, Histocell has 30 high qualified professionals and production facilities approved by the AEMPS (Spanish Agency of Medicinal products and Medical devices) in order to produce cell therapy drugs. Histocell technologies are based on the application of Adult Stem Cells and Bioactive materials as key technology, consolidating its position in the development of Tissue Engineering products.
Univet is a biotechnology veterinary company founded in 2001 as a spin-off of the Autonomous University of Barcelona, leaded by a group of researchers from the Faculty of Veterinary Medicine. Univet is focused on the research, diagnosis and treatment of pet’s dermatological diseases. Dogs and horses reconstituted skin and innovative allergic dermatitis treatments are the results of the research in animal health and knowledge in the veterinary medicine market.
Spherium Biomed, created by Janus Development and pharma company Ferrer, is a holding for biomedical projects created within academic fields. Janus licenses university and research centers projects and designs the development strategy in order to make projects attractive for the market investing their own capital to gain maturity in the project. Finally, Janus searches for suitable partners to complete the project development and commercialization.